Top Markets
Coin of the day
Bioqual, Inc. Bioqual, Inc.

Bioqual, Inc.

BIOQ
株式のランク #28015
Bioqual, Inc. delivers a range of preclinical research solutions, encompassing... Bioqual, Inc. delivers a range of preclinical research solutions, encompassing both in-vivo and in-vitro methodologies, to its diverse clientele of commercial enterprises and government agencies across the United States. Their expertise spans numerous critical health domains, including investigations into COVID-19, AIDS, influenza, RSV infection, and various flaviviruses such as Zika and Dengue. Furthermore, their work extends to malaria, hepatitis, and oncology. The firm's comprehensive laboratory capabilities further include processing biological samples, producing virus stocks, precisely quantifying infectious viral loads, and conducting assays like virus neutralization and hemagglutination inhibition. They also utilize advanced techniques such as quantitative PCR, ELISA for antigen and antibody detection, flow cytometry, lymphocyte proliferation studies, and various other cell-based analytical methods. Moreover, Bioqual furnishes specialized support for studies employing animal research models. Established in 1981, Bioqual, Inc. maintains its primary operational base in Rockville, Maryland.
株価
$32.50
最終同期: 2026-08-18
時価総額
$29.07M
変化(1日)
0.00%
変化(1年)
-24.75%
US
取引 Bioqual, Inc. (BIOQ)

カテゴリー

Bioqual, Inc.(BIOQ)の配当利回りの履歴
Bioqual, Inc.(銘柄コード: BIOQ)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Bioqual, Inc.(BIOQ)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)